论文部分内容阅读
目的:分析和探究口服特比萘芬联合外用联苯苄唑治疗手足癣的临床方法和效果。方法:对照组给予口服特比萘芬治疗,实验组患者在对照组的基础上又给予外用联苯苄唑治疗。对比两组患者的治疗效果和不良反应。结果:相关治疗之后,实验组患者的治疗总有效率为(98.33%)高于对照组的(88.33%),他们之间的数据差异具有统计学意义(P<0.05)。统计发现,在服药2天后,实验组患者中有2例出现轻微不良反应,不良反应发生率为3.33%;对照组中有8例出现轻微不良反应,不良反应发生率为13.33%。两组患者不良反应未经处理,均自行缓解,未对后期的治疗及康复产生影响,他们之间的差异具有统计学意义(P<0.05)。结论:口服特比萘芬联合外用联苯苄唑在手足癣患者临床治疗过程中具有很好的疗效,值得临床推广使用。
OBJECTIVE: To analyze and investigate the clinical effects and clinical effects of oral terbinafine combined with topical bifonazole in the treatment of hand, foot and ringworm. Methods: The control group was treated with terbinafine orally. The patients in the experimental group were treated with bifonazole on the basis of the control group. Comparison of two groups of patients with treatment and adverse reactions. Results: After the treatment, the total effective rate of the experimental group was (98.33%) higher than that of the control group (88.33%). The difference between the two groups was statistically significant (P <0.05). Statistics found that 2 days after taking the test group, 2 patients had mild adverse reactions, the incidence of adverse reactions was 3.33%; control group, 8 patients had minor adverse reactions, the incidence of adverse reactions was 13.33%. Adverse reactions in both groups were untreated, relieved on their own, did not affect the later treatment and rehabilitation, the difference between them was statistically significant (P <0.05). Conclusion: Terbinafine combined with topical bifonazole has good curative effect in the clinical treatment of hand, foot and ringworm patients and is worthy of clinical promotion.